Mutations in moderate-risk genes ATM, CHEK2, PALB2, and RAD50 confer 2- to 4-fold increased breast cancer risks5, although recent evidence suggests that the breast cancer risk conferred by PALB2 mutations may be higher than initially thought6, 7. This evidence concerns the gene CHEK2 and breast cancer.